First Citizens Bank & Trust CO Amgen Inc Transaction History

First Citizens Bank & Trust CO

  • $6.42 Billion
  • Q4 2024

A detailed history of First Citizens Bank & Trust CO transactions in Amgen Inc stock. As of the latest transaction made, First Citizens Bank & Trust CO holds 9,804 shares of AMGN stock, worth $2.78 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares
9,804
Previous 10,054 2.49%
Holding current value
$2.78 Million
Previous $3.24 Million 21.12%
% of portfolio
0.04%
Previous 0.05%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Jan 21, 2025
SELL
$258.78 - $328.31 $64,694 - $82,077
-250 Reduced 2.49%
9,804 $2.56 Million
Q3 2024

Oct 17, 2024
BUY
$309.38 - $337.38 $153,761 - $167,677
497 Added 5.2%
10,054 $3.24 Million
Q2 2024

Jul 19, 2024
BUY
$262.75 - $319.31 $1,839 - $2,235
7 Added 0.07%
9,557 $2.99 Million
Q1 2024

Apr 15, 2024
BUY
$268.87 - $324.56 $801,232 - $967,188
2,980 Added 45.36%
9,550 $2.72 Million
Q4 2023

Jan 22, 2024
BUY
$255.7 - $288.46 $113,019 - $127,499
442 Added 7.21%
6,570 $1.89 Million
Q3 2023

Oct 30, 2023
SELL
$218.65 - $271.46 $75,652 - $93,925
-346 Reduced 5.34%
6,128 $1.65 Million
Q2 2023

Aug 15, 2023
BUY
$214.27 - $253.37 $923,932 - $1.09 Million
4,312 Added 199.44%
6,474 $1.44 Million
Q1 2023

May 11, 2023
SELL
$225.79 - $275.2 $28,901 - $35,225
-128 Reduced 5.59%
2,162 $522,000
Q4 2022

Jan 24, 2023
SELL
$229.03 - $291.01 $55,196 - $70,133
-241 Reduced 9.52%
2,290 $601,000
Q3 2022

Oct 20, 2022
SELL
$224.46 - $253.15 $3,815 - $4,303
-17 Reduced 0.67%
2,531 $570,000
Q2 2022

Jul 26, 2022
BUY
$230.71 - $256.74 $148,577 - $165,340
644 Added 33.82%
2,548 $620,000
Q1 2022

Apr 26, 2022
SELL
$219.27 - $242.57 $1,096 - $1,212
-5 Reduced 0.26%
1,904 $460,000
Q4 2021

Mar 11, 2022
SELL
$198.88 - $227.6 $24,263 - $27,767
-122 Reduced 6.01%
1,909 $429,000
Q3 2021

Oct 15, 2021
SELL
$212.27 - $248.7 $56,463 - $66,154
-266 Reduced 11.58%
2,031 $431,000
Q2 2021

Jul 14, 2021
SELL
$233.58 - $259.14 $344,997 - $382,749
-1,477 Reduced 39.14%
2,297 $560,000
Q1 2021

Apr 14, 2021
SELL
$221.91 - $258.6 $12,648 - $14,740
-57 Reduced 1.49%
3,774 $939,000
Q4 2020

Jan 13, 2021
SELL
$216.38 - $257.67 $43,708 - $52,049
-202 Reduced 5.01%
3,831 $880,000
Q3 2020

Oct 15, 2020
BUY
$234.65 - $260.95 $48,807 - $54,277
208 Added 5.44%
4,033 $1.03 Million
Q2 2020

Jul 15, 2020
SELL
$197.81 - $242.74 $401,356 - $492,519
-2,029 Reduced 34.66%
3,825 $903,000
Q1 2020

Apr 17, 2020
SELL
$182.24 - $241.7 $105,699 - $140,186
-580 Reduced 9.01%
5,854 $1.19 Million
Q4 2019

Jan 15, 2020
SELL
$189.21 - $243.2 $95,551 - $122,816
-505 Reduced 7.28%
6,434 $1.55 Million
Q3 2019

Oct 18, 2019
BUY
$174.11 - $208.62 $10,968 - $13,143
63 Added 0.92%
6,939 $1.34 Million
Q2 2019

Jul 11, 2019
SELL
$166.7 - $195.41 $219,377 - $257,159
-1,316 Reduced 16.06%
6,876 $1.27 Million
Q1 2019

Apr 12, 2019
SELL
$180.87 - $203.88 $2.01 Million - $2.26 Million
-11,105 Reduced 57.55%
8,192 $1.56 Million
Q4 2018

Jan 15, 2019
BUY
$178.4 - $208.25 $1.89 Million - $2.2 Million
10,580 Added 121.37%
19,297 $3.76 Million
Q3 2018

Oct 18, 2018
SELL
$185.29 - $208.89 $78,933 - $88,987
-426 Reduced 4.66%
8,717 $1.81 Million
Q2 2018

Jul 11, 2018
SELL
$166.05 - $186.51 $267,838 - $300,840
-1,613 Reduced 15.0%
9,143 $1.69 Million
Q1 2018

Apr 11, 2018
SELL
$169.43 - $198.0 $2.51 Million - $2.93 Million
-14,789 Reduced 57.89%
10,756 $1.83 Million
Q4 2017

Jan 10, 2018
BUY
$168.79 - $188.59 $47,936 - $53,559
284 Added 1.12%
25,545 $4.44 Million
Q3 2017

Oct 12, 2017
BUY
$167.29 - $191.0 $4.23 Million - $4.82 Million
25,261
25,261 $4.71 Million

Others Institutions Holding AMGN

# of Institutions
3,083
Shares Held
401M
Call Options Held
7.56M
Put Options Held
7.16M
View Full List

About AMGEN INC

AMGN Quotes by TradingView
  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $152B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track First Citizens Bank & Trust CO Portfolio

Follow First Citizens Bank & Trust CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of First Citizens Bank & Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on First Citizens Bank & Trust CO with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email